+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Trial Packaging Market by End-user and Geography - Forecast and Analysis 2020-2024

  • PDF Icon

    Report

  • 146 Pages
  • December 2019
  • Region: Global
  • TechNavio
  • ID: 4901405
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Clinical Trial Packaging Market 2020-2024
The author has been monitoring the global clinical trial packaging market, and it is poised to grow by USD667.92 million during 2020-2024, progressing at a CAGR of over 4% during the forecast period. Our reports on global clinical trial packaging market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing approval of novel drugs. Also, the advent of AI in clinical research is anticipated to boost the growth of the global clinical trial packaging market as well.

Market Segmentation

The global clinical trial packaging market is segmented as below:

End-users
  • Pharmaceutical companies
  • Organizations

Geographic segmentation
  • Asia
  • Europe
  • North America
  • ROW

Key Trends for global clinical trial packaging market growth
This study identifies advent of AI in clinical research as the prime reason driving the global clinical trial packaging market growth during the next few years.

Prominent vendors in global clinical trial packaging market
We provide a detailed analysis of around 25 vendors operating in the global clinical trial packaging market, including some of the vendors such as Bilcare Ltd., Caligor Coghlan Pharma Services, Corden Pharma International GmbH, Mawdsley-Brooks & Co. Ltd., PCI Pharma Services, Piramal Enterprises Ltd., Sentry BioPharma Services, Sharp, The WestRock group and Thermo Fisher Scientific Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

About the Author
The author presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$

PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value chain analysis

PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market outlook

PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER
  • Market segmentation by end-user
  • Comparison by end-user
  • Pharmaceutical companies - Market size and forecast 2019-2024
  • Other organizations - Market size and forecast 2019-2024
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS
  • Advent of AI in clinical research
  • Increasing outsourcing activities to CROs
  • Increasing adoption of cloud technologies in pharmaceutical production
  • and testing

PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bilcare Ltd.
  • Caligor Coghlan Pharma Services
  • Corden Pharma International GmbH
  • Mawdsley-Brooks & Co. Ltd.
  • PCI Pharma Services
  • Piramal Enterprises Ltd.
  • Sentry BioPharma Services
  • Sharp
  • The WestRock group
  • Thermo Fisher Scientific Inc.

PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

List of Exhibits
Exhibit 01: Vendors: Key offerings
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: End-user - Market share 2019-2024 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Pharmaceutical companies - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Pharmaceutical companies - Year-over-year growth 2020-2024 (%)
Exhibit 22: Other organizations - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Other organizations - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by end-user
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Top 3 countries in North America
Exhibit 31: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 33: Top 3 countries in Europe
Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 36: Top 3 countries in Asia
Exhibit 37: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 38: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 39: Top 3 countries in ROW
Exhibit 40: Key leading countries
Exhibit 41: Market opportunity
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Bilcare Ltd. - Vendor overview
Exhibit 49: Bilcare Ltd. - Business segments
Exhibit 50: Bilcare Ltd. - Key offerings
Exhibit 51: Bilcare Ltd. - Key customers
Exhibit 52: Caligor Coghlan Pharma Services - Vendor overview
Exhibit 53: Caligor Coghlan Pharma Services - Business segments
Exhibit 54: Caligor Coghlan Pharma Services - Organizational developments
Exhibit 55: Caligor Coghlan Pharma Services - Key offerings
Exhibit 56: Caligor Coghlan Pharma Services - Key customers
Exhibit 57: Corden Pharma International GmbH - Vendor overview
Exhibit 58: Corden Pharma International GmbH - Business segments
Exhibit 59: Corden Pharma International GmbH - Organizational developments
Exhibit 60: Corden Pharma International GmbH - Key offerings
Exhibit 61: Corden Pharma International GmbH - Key customers
Exhibit 62: Mawdsley-Brooks & Co. Ltd. - Vendor overview
Exhibit 63: Mawdsley-Brooks & Co. Ltd. - Business segments
Exhibit 64: Mawdsley-Brooks & Co. Ltd. - Organizational developments
Exhibit 65: Mawdsley-Brooks & Co. Ltd. - Key offerings
Exhibit 66: Mawdsley-Brooks & Co. Ltd. - Key customers
Exhibit 67: PCI Pharma Services - Vendor overview
Exhibit 68: PCI Pharma Services - Business segments
Exhibit 69: PCI Pharma Services - Organizational developments
Exhibit 70: PCI Pharma Services - Key offerings
Exhibit 71: PCI Pharma Services - Key customers
Exhibit 72: Piramal Enterprises Ltd. - Vendor overview
Exhibit 73: Piramal Enterprises Ltd. - Business segments
Exhibit 74: Piramal Enterprises Ltd. - Organizational developments
Exhibit 75: Piramal Enterprises Ltd. - Segment focus
Exhibit 76: Piramal Enterprises Ltd. - Key offerings
Exhibit 77: Piramal Enterprises Ltd. - Key customers
Exhibit 78: Sentry BioPharma Services - Vendor overview
Exhibit 79: Sentry BioPharma Services - Business segments
Exhibit 80: Sentry BioPharma Services - Key offerings
Exhibit 81: Sentry BioPharma Services - Key customers
Exhibit 82: Sharp - Vendor overview
Exhibit 83: Sharp - Business segments
Exhibit 84: Sharp - Organizational developments
Exhibit 85: Sharp - Geographic focus
Exhibit 86: Sharp - Key offerings
Exhibit 87: Sharp - Key customers
Exhibit 88: The WestRock group - Vendor overview
Exhibit 89: The WestRock group - Business segments
Exhibit 90: The WestRock group - Organizational developments
Exhibit 91: The WestRock group - Segment focus
Exhibit 92: The WestRock group - Key offerings
Exhibit 93: The WestRock group - Key customers
Exhibit 94: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 95: Thermo Fisher Scientific Inc. - Business segments
Exhibit 96: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 97: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 98: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 99: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 100: Thermo Fisher Scientific Inc. - Key customers
Exhibit 101: Validation techniques employed for market sizing
Exhibit 102: Definition of market positioning of vendors

Executive Summary

The following companies as the key players in the Global Clinical Trial Packaging Market: Bilcare Ltd., Caligor Coghlan Pharma Services, Corden Pharma International GmbH, Mawdsley-Brooks & Co. Ltd., PCI Pharma Services, Piramal Enterprises Ltd., Sentry BioPharma Services, Sharp, The WestRock group and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the advent of AI in clinical research.”

According to the report, one of the major drivers for this market is the increasing approval of novel drugs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bilcare Ltd.
  • Caligor Coghlan Pharma Services
  • Corden Pharma International GmbH
  • Mawdsley-Brooks & Co. Ltd.
  • PCI Pharma Services
  • Piramal Enterprises Ltd.
  • Sentry BioPharma Services
  • Sharp
  • The WestRock group
  • Thermo Fisher Scientific Inc.